Beverly Hills Private Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Beverly Hills Private Wealth, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $43.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$43.3M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 57,121 | $9.4M |
| ELVElevance Health Inc. | 19,575 | $5.7M |
| JNJJOHNSON & JOHNSON | 23,022 | $5.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 17,726 | $4.8M |
| ABBVAbbVie Inc. | 12,474 | $2.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 42,432 | $2.3M |
| NVONovo Nordisk A/S | 50,343 | $1.9M |
| MRKMerck & Co., Inc. | 13,899 | $1.7M |
| ABTABBOTT LABORATORIES | 12,230 | $1.3M |
| MCKMcKesson Corporation | 1,444 | $1.2M |
| NVSNovartis AG | 7,871 | $1.2M |
| LLYELI LILLY & Co | 1,128 | $1.0M |
| AMGNAMGEN INC | 2,461 | $866K |
| SNYSanofi | 14,891 | $717K |
| ZTSZoetis Inc. | 5,074 | $600K |
| PFEPFIZER INC | 16,264 | $457K |
| BMYBRISTOL MYERS SQUIBB CO | 7,092 | $430K |
| DVADaVita Inc. | 2,615 | $402K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 19,973 | $370K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,505 | $260K |
| QGENQIAGEN N.V. | 5,728 | $229K |
| LCTXLineage Cell Therapeutics, Inc. | 10,000 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.